Estimating Lead Time and Sensitivity in a Screening Program without Estimating the Incidence in the Screened Group

DOI10.2307/2533109zbMATH Open0874.62137OpenAlexW2096498044WikidataQ73331816 ScholiaQ73331816MaRDI QIDQ4350021FDOQ4350021

Authors Huub Straatman, Petronella G. M. Peer, André L. M. Verbeek

Publication date 9 November 1997

Published in Biometrics (Search for Journal in Brave)

Full work available at URL https://doi.org/10.2307/2533109

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• Simplified Models of Screening for Chronic Disease: Estimation Procedures from Mass Screening Programmes
• A review of estimation of key parameters and lead time in cancer screening
• Bayesian Inference for the Lead Time in Periodic Cancer Screening
• How well can screening sensitivity and sojourn time be estimated
• Computer simulation of randomized cancer screening trials to compare methods of estimating lead time and benefit time

Cited in

(23)

• Quantification of length-bias in screening trials with covariate-dependent test sensitivity
• An age dependent stochastic model of periodic screening: Length bias at a prevalence screen
• scientific article; zbMATH DE number 3956291 (Why is no real title available?)
• Inference of long term effects and overdiagnosis in periodic cancer screening
• Parametric estimation procedures for screening programmes: stable and nonstable disease models for multimodality case finding
• A Note on the Sensitivities of Self-reporting and Screen Detection of Primary Breast Tumours
• Early detection of disease and scheduling of screening examinations
• Estimation of Sojourn Time in Chronic Disease Screening Without Data on Interval Cases
• The effect on survival of early detection of breast cancer in South Australia
• Robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distribution
• A review of estimation of key parameters and lead time in cancer screening
• Nonparametric Estimation of Asymptomatic Duration from a Randomized Prospective Cancer Screening Trial
• Significance Tests for Cancer Screening Trials
• How well can screening sensitivity and sojourn time be estimated
• A stochastic model for calibrating the survival benefit of screen-detected cancers
• Bayesian Inference for the Lead Time in Periodic Cancer Screening
• Estimating the Cumulative Risk of a False-Positive Test in a Repeated Screening Program
• MLE and Bayesian Inference of Age-Dependent Sensitivity and Transition Probability in Periodic Screening
• The Natural History of Lung Cancer in a Periodically Screened Population
• Estimating distribution of the age of onset of detectable asymptomatic cancer
• Estimating Lead Time and Overdiagnosis Associated with PSA Screening from Prostate Cancer Incidence Trends
• Bayesian assessment of times to diagnosis in breast cancer screening
• Evaluating the Age to Begin Periodic Breast Cancer Screening Using Data from a Few Regularly Scheduled Screenings

This page was built for publication: Estimating Lead Time and Sensitivity in a Screening Program without Estimating the Incidence in the Screened Group

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4350021)